Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Biotech name Travere Therapeutics is not profitable yet but a turnaround may be around the corner as the stock hovers near a buy zone.
The post Travere Therapeutics Outlook Brightens As Turnaround Looms appeared first on Investor’s Business Daily.
